表紙
市場調查報告書

北美的遺傳基因檢驗服務市場 - 各類型、疾病、服務供應商、各國市場分析與預測

North America Genetic Testing Services Market to 2027 - Regional Analysis and Forecasts by Type, Disease, Service Provider and Country

出版商 The Insight Partners 商品編碼 928818
出版日期 內容資訊 英文 172 Pages
訂單完成後即時交付
價格
北美的遺傳基因檢驗服務市場 - 各類型、疾病、服務供應商、各國市場分析與預測 North America Genetic Testing Services Market to 2027 - Regional Analysis and Forecasts by Type, Disease, Service Provider and Country
出版日期: 2020年02月28日內容資訊: 英文 172 Pages
簡介

北美的遺傳基因檢驗服務的市場規模在2019年估算為30億4,440萬美元,從2020年到2027年間預測將以12.1%的年複合成長率發展,並成長到74億600萬美元的規模。由於遺傳基因疾病的盛行率上升,及個人化醫療的普及認識度的提高,消費者直接連接型(DTC)遺傳基因檢驗服務的偏好的高漲等促進該市場成長。

本報告提供北美的遺傳基因檢驗服務市場調查,市場概要,各類型、疾病、服務供應商、各國市場規模的變化與預測,市場佔有率,收益預測,市場成長要素及阻礙因素分析,市場機會,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 簡介

  • 調查範圍
  • The Insight Partners調查指導

第2章 重要點

第3章 市場形勢

  • 概要
  • 市場區隔
  • PEST分析
  • 專家的意見

第4章 市場動態

  • 主要的成長要素
  • 主要的阻礙因素
  • 遺傳基因檢驗的社會及道德性影響
  • 主要的市場機會
  • 今後趨勢
  • 成長要素及阻礙因素的影響分析

第5章 北美的遺傳基因檢驗服務市場分析

  • 北美的遺傳基因檢驗服務市場收益預測與分析
  • 市場定位
  • 主要企業的效能

第6章 北美的遺傳基因檢驗服務市場:各類型

  • 概要
  • 市場佔有率:各類型(成果值、預測值)
  • 收益預測:各類型
  • 新生兒篩檢
  • 產前檢查
  • 預測的遺傳基因檢驗
  • 電信業者試驗
  • 其他

第7章 北美的遺傳基因檢驗服務市場:各疾病

  • 概要
  • 市場佔有率:各疾病(成果值、預測值)
  • 收益預測:各疾病
  • 癌症
  • 代謝性疾病
  • 心血管疾病
  • 其他

第8章 北美的遺傳基因檢驗服務市場:各服務供應商

  • 概要
  • 市場佔有率:各服務供應商(成果值、預測值)
  • 收益預測:各疾病
  • 診斷研究所
  • 醫院內研究所
  • 診療所

第9章 北美的遺傳基因檢驗服務市場:各國

  • 概要
  • 市場佔有率:各國

第10章 產業形勢

  • 概要
  • 成長策略
  • 有機開發
  • 無機開發

第11章 企業簡介

  • Laboratory Corporation of America Holdings
  • F. HOFFMANN-LA ROCHE LTD
  • Illumina, Inc.
  • Quest Diagnostics Incorporated
  • Exact Sciences Corporation
  • NeoGenomics Laboratories, Inc.
  • Eurofins Scientific
  • Ambry Genetics
  • Centogene AG
  • andMe, Inc.
  • THERMO FISHER SCIENTIFIC INC.

第12章 附錄

  • 關於The Insight Partners
  • 詞彙表
  • 調查手法
目錄
Product Code: TIPRE00009262

The North America genetic testing services market is expected to reach US$ 7,406.0 Mn in 2027 from US$ 3,044.4 Mn in 2019. The genetic testing services market is anticipated to grow at a growth rate of 12.1% from 2020-2027.

The factors driving the growth of genetic testing service include rising prevalence of the genetic diseases and rise in awareness & acceptance of personalized medicines. Also, growing preference towards Direct-To-Consumer (DTC) genetic testing, support of government to adopt genetic testing services is positively impacting the growth of the market in the review period. In addition, various strategic initiatives by the manufacturers, new product launch along with artificial intelligence (AI) powered genetic testing is likely to boost the growth of market.

Moreover, increasing focus on advanced method incorporation in healthcare, government and private initiatives for promotion of precision medicine and massive funds from government and private bodies for genetic research is further expected stimulate the growth and contribute to exceptional revenue generation for the genetic testing services market in North America.

The demand for genetic testing in the United States has been expected to witness growth, since the service encompasses a broad range of applications such as, cancer, autoimmune diseases and infectious diseases. In US, the products for genetic testing of pediatric as well as rare diseases has increased significantly. As per the estimates of National Institutes of Health (NIH), in the United States, there are around 25 to 30 million people suffering from rare diseases, accounting for individuals fewer than 200,000 people. Rare diseases are often the result of a genetic mutation; one estimate is that 80% of rare diseases are genetic in nature. Also, 50% of patients with rare diseases are children.

There has been a significant rise in the cases of rare diseases in US during the last decade. In 2009, there were 5,857 catalogued rare disorders, whereas 6,084 number of rare diseases were recorded in 2016, accounting a rate of approximately 30 new rare diseases per year.

Thus the increasing funds and awareness in North America are likely to boost the genetic testing services market and are anticipated to provide significant growth opportunities to the players operating in the market during the forecast period.

The above-mentioned factors are expected to offer broad growth opportunities in the industry, and this is expected to cause the demand for genetic testing services.

North America genetic testing services market is segmented by type, disease, and service provider. Based on the type, the market is segmented into predictive testing, carrier testing, prenatal testing, newborn screening and others. On the basis of disease, the market is classified as, cancer disease, metabolic diseases, cardiovascular diseases and others. Based on service provider, the market is categorized as, diagnostic laboratories, hospital-based laboratories and clinics.

Some of the major primary and secondary sources for genetic testing services market included in the report are World Health Organization (WHO), Clinical Laboratory Improvement Amendments (CLIA), National Institutes of Health (NIH), the North American Cancer Information System among others.

Reasons to Buy

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the genetic testing services market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the North America genetic testing services market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table of Contents

1. Introduction

  • 1.1 Scope Of The Study
  • 1.2 The Insight Partners Research Report Guidance

2. North America Genetic Testing Services Market - Key Takeaways

3. North America Genetic Testing Services Market - Market Landscape

  • 3.1 Overview
  • 3.2 Market Segmentation
    • 3.2.1 North America Genetic Testing Services Market - By Type
    • 3.2.2 North America Genetic Testing Services Market - By Disease
    • 3.2.3 North America Genetic Testing Services Market - By Service Provider
    • 3.2.4 North America Genetic Testing Services Market - By Country
  • 3.3 PEST Analysis
  • 3.4 Expert Opinions

4. North America Genetic Testing Services Market-Key Market Dynamics

  • 4.1 Key Market Drivers
    • 4.1.1 Rising Prevalence of Genetic Diseases in North America
    • 4.1.2 Rise in Awareness & Acceptance of Personalized Medicines
  • 4.2 Key Market Restraints
  • 4.3 Social and Ethical Implications of Genetic Testing
  • 4.4 Key Market Opportunities
    • 4.4.1 Growing Preference towards Direct-To-Consumer (DTC) Genetic Testing in North America
  • 4.5 Future Trends
    • 4.5.1 Artificial Intelligence (AI) Powered Genetic Testing
  • 4.6 Impact Analysis Of Drivers And Restraints

5. Genetic Testing Services Market - North America Analysis

  • 5.1 North America Genetic Testing Services Market Revenue Forecasts And Analysis
  • 5.2 Market Positioning
  • 5.3 Performance Of Key Players
    • 5.3.1 Thermo Fischer Scientific Inc.,
    • 5.3.2 F. Hoffmann-La Roche Ltd
    • 5.3.3 Illumina, Inc.

6. North America Genetic Testing Services Market Analysis - By Type

  • 6.1 Overview
  • 6.2 North America Genetic Testing Services Market, By Type, 2019 & 2027 (%)
  • 6.3 North America Genetic Testing Services Market Revenue And Forecasts To 2027, By Type (Us$ Mn)
  • 6.4 New-born Screening Market
    • 6.4.1 Overview
    • 6.4.2 New-born Screening Market Revenue and Forecast to 2027 (US$ Mn)
  • 6.5 Prenatal Testing Market
    • 6.5.1 Overview
    • 6.5.2 Prenatal Testing Market Revenue and Forecast to 2027 (US$ Mn)
  • 6.6 Predictive Testing Market
    • 6.6.1 Overview
    • 6.6.2 Predictive Testing Market Revenue and Forecast to 2027 (US$ Mn)
  • 6.7 Carrier Testing Market
    • 6.7.1 Overview
    • 6.7.2 Carrier Testing Market Revenue and Forecast to 2027 (US$ Mn)
  • 6.8 Other Testing's Market
    • 6.8.1 Overview
    • 6.8.2 Other Testing's Market Revenue and Forecast to 2027 (US$ Mn)

7. North America Genetic Testing Services Market Analysis - By Disease

  • 7.1 Overview
  • 7.2 North America Genetic Testing Services Market, By Disease, 2019 & 2027 (%)
  • 7.3 North America Genetic Testing Services Market Revenue And Forecasts To 2027, By Disease (Us$ Mn)
  • 7.4 Cancer Market
    • 7.4.1 Overview
    • 7.4.2 Cancer Market Revenue and Forecast to 2027 (US$ Mn)
  • 7.5 Metabolic Diseases Market
    • 7.5.1 Overview
    • 7.5.2 Metabolic Diseases Market Revenue and Forecast to 2027 (US$ Mn)
  • 7.6 Cardiovascular Disease Market
    • 7.6.1 Overview
    • 7.6.2 Cardiovascular Disease Market Revenue and Forecast to 2027 (US$ Mn)
  • 7.7 Other Diseases Market
    • 7.7.1 Overview
    • 7.7.2 Other Diseases Market Revenue and Forecast to 2027 (US$ Mn)

8. North America Genetic Testing Services Market Analysis - By Service Provider

  • 8.1 Overview
  • 8.2 North America Genetic Testing Services Market, By Service Provider, 2019 & 2027 (%)
  • 8.3 North America Genetic Testing Services Market Revenue And Forecasts To 2027, By Disease (Us$ Mn)
  • 8.4 Diagnostic Laboratories Market
    • 8.4.1 Overview
    • 8.4.2 Diagnostic Laboratories Market Revenue and Forecast to 2027 (US$ Mn)
  • 8.5 Hospital-Based Laboratories Market
    • 8.5.1 Overview
    • 8.5.2 Hospital-Based Laboratories Market Revenue and Forecast to 2027 (US$ Mn)
  • 8.6 Clinics Market
    • 8.6.1 Overview
    • 8.6.2 Clinics Market Revenue and Forecast to 2027 (US$ Mn)

9. North America Genetic Testing Services Market Revenue And Forecasts To 2027

  • 9.1 Overview
  • 9.2 North America Genetic Testing Services Market Revenue And Forecasts To 2027, By Country (%)
    • 9.2.1 US Genetic Testing Services Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.2.2 US Genetic Testing Services Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.2.2.1 US Genetic Testing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 9.2.2.2 US Genetic Testing Services Market Revenue And Forecasts to 2027, By Disease (US$ Mn)
      • 9.2.2.3 US Genetic Testing Services Market, Revenue and Forecast to 2027, by Service Provider (US$ Mn)
    • 9.2.3 Canada Genetic Testing Services Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.2.4 Canada Genetic Testing Services Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.2.4.1 Canada Genetic Testing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 9.2.4.2 Canada Genetic Testing Services Market Revenue And Forecasts to 2027, By Disease (US$ Mn)
      • 9.2.4.3 Canada Genetic Testing Services Market Revenue And Forecasts to 2027, By Service Provider (US$ Mn)
    • 9.2.5 Mexico Genetic Testing Services Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.2.6 Mexico Genetic Testing Services Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.2.6.1 Mexico Genetic Testing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 9.2.6.2 Mexico Genetic Testing Services Market Revenue And Forecasts to 2027, By Disease (US$ Mn)
      • 9.2.6.3 Mexico Genetic Testing Services Market Revenue And Forecasts to 2027, By Service Provider (US$ Mn)

10. Genetic Testing Services Market -Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies In The Genetic Testing Services Market, 2017-2020
  • 10.3 Organic Developments
    • 10.3.1 Overview
    • 10.3.2 Organic Growth Strategies In The Genetic Testing Services Market, 2017-2020
  • 10.4 Inorganic Developments
    • 10.4.1 Overview
    • 10.4.2 Inorganic Growth Strategies In The Genetic Testing Services Market, 2017-2020

11. Genetic Testing Services Market- Key Company Profiles

  • 11.1 Laboratory Corporation of America Holdings
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 F. HOFFMANN-LA ROCHE LTD
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Illumina, Inc.
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Quest Diagnostics Incorporated
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Exact Sciences Corporation
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 NeoGenomics Laboratories, Inc.
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Eurofins Scientific
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Ambry Genetics
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 Centogene AG
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10andMe, Inc.
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Products and Services
    • 11.10.4 Financial Overview
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments
  • 11.11 THERMO FISHER SCIENTIFIC INC.
    • 11.11.1 Key Facts
    • 11.11.2 Business Description
    • 11.11.3 Products and Services
    • 11.11.4 Financial Overview
    • 11.11.5 SWOT Analysis
    • 11.11.6 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary Of Terms
  • 12.3 Methodology
    • 12.3.1 Coverage
    • 12.3.2 Secondary Research
    • 12.3.3 Primary Research

LIST OF TABLES

  • Table 1. North America Genetic Testing Services market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 2. North America Genetic Testing Services market Revenue And Forecasts to 2027, By Disease (US$ Mn)
  • Table 3. North America Genetic Testing Services market Revenue And Forecasts to 2027, By disease (US$ Mn)
  • Table 4. US Genetic Testing Services market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 5. US Genetic Testing Services market Revenue And Forecasts to 2027, By Disease (US$ Mn)
  • Table 6. US Genetic Testing Services Market, Revenue and Forecast To 2027, by Service Provider (US$ Mn)
  • Table 7. Canada Genetic Testing Services market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 8. Canada Genetic Testing Services market Revenue And Forecasts to 2027, By Disease (US$ Mn)
  • Table 9. Canada Genetic Testing Services market Revenue And Forecasts to 2027, By Service Provider (US$ Mn)
  • Table 10. Mexico Genetic Testing Services market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 11. Mexico Genetic Testing Services market Revenue And Forecasts to 2027, By Disease (US$ Mn)
  • Table 12. Mexico Genetic Testing Services market Revenue And Forecasts to 2027, By Service Provider (US$ Mn)
  • Table 13. Recent Organic Growth Strategies In The Genetic Testing Services Market
  • Table 14. Recent Inorganic Growth Strategies In The Genetic Testing Services Market
  • Table 15. Glossary of Terms, Genetic Testing Services market

LIST OF FIGURES

  • Figure 1. US Genetic Testing Services Market, Revenue (US$ Mn), By 2019 & 2027
  • Figure 2. North America Genetic Testing Services Market By Type , Market Share (%), 2019
  • Figure 3. North America Genetic Testing Services Market By Disease, Market Share (%), 2019
  • Figure 4. North America Genetic Testing Services Market By Service Provider, Market Share (%), 2019
  • Figure 5. Genetic Testing Services Market Segmentation
  • Figure 6. North America PEST Analysis
  • Figure 7. Genetic Testing Services Market Impact Analysis Of Driver And Restraint
  • Figure 8. North America Genetic Testing Services Market - Revenue Forecasts And Analysis - 2019- 2027
  • Figure 9. North America Genetic Testing Services Market By Type, 2019 & 2027 (%)
  • Figure 10. New-born Screening Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 11. Prenatal Testing Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 12. Predictive Testing Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 13. Carrier Testing Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 14. Other Testing's Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 15. North America Genetic Testing Services Market By Disease, 2019 & 2027 (%)
  • Figure 16. Cancer Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 17. Metabolic Disease Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 18. Cardiovascular Disease Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 19. Other Diseases Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 20. North America Genetic Testing Services Market By Service Provider, 2019 & 2027 (%)
  • Figure 21. Diagnostic Laboratories Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 22. Hospital-Based Laboratories Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 23. Clinics Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 24. North America Genetic Testing Services Market REVENUE, By Country, 2019 (US$ MN)
  • Figure 25. North America Genetic Testing Services Market Revenue And Forecasts To 2027, By Country (%)
  • Figure 26. US Genetic Testing Services Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 27. Canada Genetic Testing Services Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 28. Mexico Genetic Testing Services Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 29. Growth Strategies In The Genetic Testing Services Market, 2017-2020